Oenon Holdings, Inc. engages in development of alcoholic beverages, food products, enzymes and pharmaceuticals, real estate, and other businesses based on biotechnologies derived from fermentation technologies in Japan. The company offers alcoholic beverages, including shochu, sake, plum wine/ liqueurs, spirits, ready-to-drink alcoholic beverages, and imported wine. It also manufactures and sells enzymes for food and industrial use comprising lactase, a lactose degradation; cellulase, used in processing of cereals, vegetables, and fruits; glucose isomerase, a fructose corn syrup manufacturing enzyme; protease, a protein degradation enzyme; inulinase which is used in inulo-oligosaccharide manufacturing; dispase, a cell dispersion enzyme; and isoamylase, a starch saccharification enzyme. In addition, the company offers active pharmaceutical ingredients; contract manufacturing services; starch for food processing; and diagnostic medicines and health foods. Further, it sells and leases real estate properties. Additionally, the company engages in transportation and cargo handling, and other activities. Oenon Holdings, Inc. was incorporated in 1920 and is headquartered in Tokyo, Japan.
Stock data | 2024 | Change |
---|---|---|
Price | $2.72 | N/A |
Market Cap | $158.40M | N/A |
Shares Outstanding | 58.21M | N/A |
Employees | 803.00 | N/A |